Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Investigating the Pharmacokinetics and Pharmacodynamics of Recombinant Human Insulin Administered by Dry Powder Inhaler

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2007 by QDose Limited.
Recruitment status was:  Not yet recruiting
Sponsor:
Information provided by:
QDose Limited
ClinicalTrials.gov Identifier:
NCT00426920
First received: January 24, 2007
Last updated: NA
Last verified: January 2007
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given